Influenza vaccination for health-care workers who work with elderly people in institutions: a systematic review

The Lancet Infectious Diseases
R E ThomasD Rivetti

Abstract

Our aim was to review the evidence of efficacy and effectiveness of influenza vaccination of health-care workers in reducing cases of influenza-like illness, influenza, complications from influenza, death from influenza, and death from all causes among the elderly people they care for in institutions. We searched 11 electronic databases in any language and identified two cluster-randomised controlled trials with moderate risk of bias and one cohort study at high risk of bias that addressed our questions. Staff vaccination had a significant effect on influenza-like illness (vaccine effectiveness [VE] 86%, 95% CI 40-97%) only when patients were vaccinated too. If patients were not vaccinated, staff immunisation had no effect. Vaccinating health-care workers did not appear efficacious against influenza (RR 0.87, 95% CI 0.46-1.63). There was no significant effect of vaccination on lower respiratory tract infections: (RR 0.70, 95% CI 0.41-1.20). Deaths from pneumonia were significantly reduced (VE 39%, 95% CI 2-62%), as were deaths from all causes (VE 40%, 95% CI 27-50%). These findings must be interpreted in the light of possible selection, performance, attrition, and detection biases.

Associated Clinical Trials

References

Jun 1, 1992·Journal of the American Geriatrics Society·F B ColesD L Morse
Jun 28, 2003·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Karin ThurskyHeath Kelly
Dec 3, 2003·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Richard A MartinelloJeffrey E Topal
Aug 30, 2005·Scandinavian Journal of Infectious Diseases·Siiri TormKatrin Lang
Dec 20, 2005·Lancet·Lone SimonsenRobert Taylor

❮ Previous
Next ❯

Citations

Jan 1, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kristin L NicholEdward Ehlinger
Mar 26, 2011·BMC Infectious Diseases·Bjorn J BrandsaeterBente M Bergersen
Sep 13, 2012·International Journal of General Medicine·Raywat DeonandanKathryn N Suh
Dec 4, 2013·Clinical Medicine : Journal of the Royal College of Physicians of London·Anthony IsaacsSonya Abraham
Feb 13, 2014·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Elling Ulvestad
Feb 12, 2014·Vaccine·Cornelius RemschmidtThomas Harder
Feb 1, 2011·Médecine et maladies infectieuses·P GaspardUNKNOWN Les référents GROG Géronto-Alsace
May 7, 2014·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·R Huttunen, J Syrjänen
Nov 30, 2013·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Bjørn HanebergSiri Mjaaland
Jun 12, 2010·American Journal of Preventive Medicine·Jessica N KentJo Morgan
Feb 21, 2009·Vaccine·Kristin L Nichol
Aug 5, 2008·Médecine et maladies infectieuses·P PinaA Teixeira
Aug 18, 2009·Journal of the American Geriatrics Society·Magali LemaitreFabrice Carrat
Jan 8, 2009·Journal of Evaluation in Clinical Practice·Antoine DuclosUNKNOWN Avancées Vaccinales Experts' Group
Nov 19, 2011·Journal of the American Geriatrics Society·Remko EnserinkUNKNOWN Sentinel Surveillance Network on Infectious Diseases in Nursing Homes Study Group
Dec 12, 2012·Vaccine·Alexandra M Stewart, Marisa A Cox
Apr 5, 2011·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Lynne V KaranfilWilliam L Thomas
Feb 9, 2008·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Marta H LopesAntonio A Barone
Oct 2, 2007·Scandinavian Journal of Infectious Diseases·Helen C MaltezouIoannis N Pierroutsakos
Oct 29, 2009·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Tara N PalmoreDavid K Henderson
Jun 1, 2008·Expert Review of Respiratory Medicine·Catherine W M Ong, Paul Ananth Tambyah
Aug 20, 2016·Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC·Blake ZieglerNancy Waite
Aug 9, 2017·Human Vaccines & Immunotherapeutics·Guglielmo DiniPaolo Durando
Nov 13, 2007·Journal of Occupational and Environmental Medicine·Lawrence W Raymond, Laura Leach
Feb 10, 2009·European Journal of Epidemiology·Sophie VauxJean-Claude Desenclos
Dec 17, 2009·Blood·Corey CasperMichael Boeckh
Aug 8, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Larry K PickeringUNKNOWN Infectious Diseases Society of America

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.